Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @CHDR_NL
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @CHDR_NL
-
In collaboration with the University of Twente we have recently investigated the possibility to simultaneously obtain information on psychophysical and neurophysiological properties of nociceptive processing. Read more in our recent publication: https://chdr.nl/library/simultaneous-tracking-of-psychophysical-detection-thresholds-and-evoked-potentials-to-study-nociceptive-processing …pic.twitter.com/3EBlxPXkcU
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Het CHDR zoekt een ambitieuze en ervaren Senior IT Systeembeheerder (32-40 uur per week). Ben jij de technische held die voor monitoring, technisch onderhoud en ontwikkeling van onze IT-systemen gaat zorgen?https://chdr.nl/careers/senior-it-systeembeheerder-32-40-uur-per-week …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We have recently assessed RSV-specific neutralizing antibodies in 290 healthy adult volunteers in order to help determine a cut-off serum titer that can be used as an eligibility criterion in early phase RSV vaccine trials. Read the full publication here: https://chdr.nl/library/prevalent-levels-of-rsv-serum-neutralizing-antibodies-in-healthy-adults-outside-the-rsv-season …pic.twitter.com/R0hk6PJIzB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CHDR proslijedio/la je Tweet
@CHDR_NL’s Geert Jan Groeneveld will oversee the clinical QSPainRelief studies to assess the clinical efficacy and adverse effects of selective analgesic treatments.#ChronicPain#ClinicalEfficacyAnalgesia@pain_europe@IMI_PainCare@EU_H2020@SIP_PainPolicy@IASPpain@EFIC_orgpic.twitter.com/dXSMWqOl3s
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are proud to be part of the
@QSPainRelief consortium! With this Horizon2020 funded QSPainRelief project we aim to develop effective drug combination treatments for the improved relief of chronic pain. We are kicking off this week! More info: https://www.qspainrelief.eu/#H2020pic.twitter.com/IvLNGJJuKO
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In collaboration with
@ZonMw and@FuturelabLeiden, we have developed the ‘question-based clinical development’ project valuation method. It is now fully described in the latest issue of@NatureBiotech: https://chdr.nl/news/new-nature-biotechnology-paper-integrating-scientific-considerations-into-rd-project-valuation …pic.twitter.com/FBLIG424KR
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Het CHDR zoekt een ANALIST voor de duur van minimaal 6 maanden (32-40 uur per week). Heb jij HBO werk- en denkniveau, relevante ervaring in het lab, en ben je op korte termijn beschikbaar? Klik dan hier voor meer informatie: https://chdr.nl/careers/analist-32-40-uur-per-week …
#vacaturepic.twitter.com/56Lkgnv9GG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In a recent collaborative effort, Takeda Pharmaceuticals International, Inc., Harvard Medical School and CHDR have assessed Transcranial Magnetic Stimulation (TMS) as a translational biomarker for modulation of AMPA receptor function. Read more here: https://chdr.nl/library/transcranial-magnetic-stimulation-as-a-translational-biomarker-for-modulation-of-ampa-receptor-function/download …pic.twitter.com/GIewf05tHo
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our colleague Michiel van Esdonk successfully defended his PhD thesis ‘The Quantification of Growth Hormone Secretion – Application of model-informed drug development in acromegaly’ at Leiden University! https://chdr.nl/news/dr-michiel-van-esdonk-successfully-defends-his-phd-thesis …pic.twitter.com/SdGuB3uxKB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Bart Mooy, onze Financial Director, geeft een kijkje in onze financiële processen in het artikel "Van lappendeken naar fundering: de rode draad van CHDR" in O-Magazine! Lees het artikel hier: https://www.optimo.nl/webviewer/magazine/ …pic.twitter.com/EvZ0phhias
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What will the future of clinical trial design look like? We envision a shift towards value-based trial design: a paradigm that mirrors value-based thinking in business and healthcare. Read more in our new publication:https://chdr.nl/library/the-future-of-clinical-trial-design-the-transition-from-hard-endpoints-to-value-based-endpoints …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
This week
@RissmannRobert, Research Director Dermatology, will co-lead a workshop on 'Novel translational & clinical development approaches for topicals' at the Dermatology Drug Development Summit in Boston! Join him or meet us throughout the conference!https://dermatology-drugdevelopment.com/Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We zijn op zoek naar een talentvolle arts die het leuk vindt om een bijdrage te leveren aan klinisch geneesmiddelonderzoek. In deze functie doorloop je een promotietraject binnen het vakgebied Klinische Farmacologie, specifiek gericht op Neurologie.https://chdr.nl/careers/arts-onderzoeker-neurologie-promotieplaats-neurofarmacologie …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Working at CHDR, investing in your future! Last week a group of employees has received a certificate for successfully completing the in company training 'legislation & clinical research' by Breederode Hogeschool, and more are to follow! Job opportunities: https://chdr.nl/careers pic.twitter.com/iVjWjrWEeD
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Wij zijn op zoek naar een leerling-laborant klinische neurofysiologie (36-40 uur per week)! Naast een uitdagende werkomgeving bieden wij een leer-arbeidsplaats van drie tot vier jaar aan. Klik hier voor meer informatie: https://chdr.nl/careers/leerling-laborant-klinische-neurofysiologie-36-40-uur-per-week …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
A renewed, interactive version of Teaching Resource Centre (TRC)®, CHDR’s freely available online clinical pharmacology platform, is available now!https://chdr.nl/news/renewed-interactive-version-of-teaching-resource-centre-trc-chdrs-online-clinical-pharmacology-platform-is-available-now …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Wij zijn verheugd over ons partnerschap met Rijksmuseum Boerhaave. Samen zullen wij biomedisch onderzoek zichtbaar en toegankelijk maken voor een breed publiek.https://twitter.com/museumboerhaave/status/1187283311439306753 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Vanavond om 20:15 start de derde editie van WAVELENGTH op het CHDR. Kom kijken en luisteren naar deze bijzondere combinatie van muziek en wetenschap, vandaag en morgen in het Leiden Bio Science Park! Voor meer info: http://www.wavelengthleiden.nl/ pic.twitter.com/HEjopm2xvx
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr Kawita Kanhai has successfully defended her PhD thesis! Kawita conducted research at CHDR on 'measuring pharmacodynamics in early clinical drug studies in multiple sclerosis'. Read her thesis here: https://chdr.nl/news/dr-kawita-kanhai-successfully-defends-her-phd-thesis …pic.twitter.com/0wxpTnnIyL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
This week we presented 2 abstract presentations at the conference 'Shaping the future of Pediatrics' in Rome. The abstracts covered our Trial@home platform and our machine learning algorithm for crying detection in infants. We are proud to contribute to innovation in Pediatrics!pic.twitter.com/Tvis2sdIBC
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.